Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma
Uterine leiomyosarcoma (ULMS) is the most lethal gynecologic malignancy with few therapeutic options. Chemoresistance prevails as a major hurdle in treating this malignancy, yet the mechanism of chemoresistance remains largely unclear. In this study, we certified MELK as a poor prognostic marker thr...
Main Authors: | Zhiwei Zhang, Chenggong Sun, Chengcheng Li, Xinlin Jiao, Brannan B. Griffin, Samina Dongol, Huan Wu, Chenyi Zhang, Wenyu Cao, Ruifen Dong, Xingsheng Yang, Qing Zhang, Beihua Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00453/full |
Similar Items
-
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
by: Chenggong Sun, et al.
Published: (2020-01-01) -
Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK
by: Xianling Gong, et al.
Published: (2018-05-01) -
MELK is not necessary for the proliferation of basal-like breast cancer cells
by: Hai-Tsang Huang, et al.
Published: (2017-09-01) -
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells
by: Li H, et al.
Published: (2020-04-01) -
Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review
by: Congcong Li, et al.
Published: (2019-03-01)